Related Experiment Video
Updated: May 13, 2026
An Adipocyte Cell Culture Model to Study the Impact of Protein and Micro-RNA Modulation on Adipocyte Function
Published on: May 4, 2021
Scutellarin from Scutellaria baicalensis suppresses adipogenesis by upregulating PPARα in 3T3-L1 cells
Kaihui Lu1, Miaomiao Han, Hui Lin Ting
1Division of Chemistry and Biological Chemistry, School of Physical and Mathematical Sciences, Nanyang Technological University, Singapore 637371, Singapore.
Abstract:
Adipocyte dysfunction is a major cause of obesity, which is associated strongly with many disorders including psychological and medical morbidities, metabolic abnormalities, and cardiovascular diseases as well as a series of cancers. This study investigated the antiadipogenic activity of scutellarin (1) in 3T3-L1 preadipocytes as well as the underlying molecular mechanisms. It was observed that 1 reduced adipocyte differentiation of 3T3-L1 cells potently, as evidenced by a decrease in cellular lipid accumulation. At the molecular level, mRNA expression of the master adipogenic transcription factors, PPARγ and C/EBPα, was decreased markedly. However, mRNA levels of C/EBPβ, the upstream regulator of PPARγ and C/EBPα, were not decreased by 1. Moreover, a dose-dependent upregulation of PPARα was observed for 1. Computational modeling indicated that 1 can bind to PPARα, γ, and δ each in a distinct manner, while it can activate PPARα only by forming a hydrogen bond with Y464, thus stabilizing the AF-2 helix and activating PPARα. Therefore, these results suggest that 1, a major component of Scutellaria baicalensis, attenuates fat cell differentiation by upregulating PPARα as well as downregulating the expression of PPARγ and C/EBPα, thus showing therapeutic potential for obesity-related diseases.
Insights
Scutellarin effectively reduces fat cell differentiation by downregulating PPARγ and C/EBPα, while upregulating PPARα. This compound shows therapeutic potential for obesity-related diseases.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Adipocyte dysfunction is a key driver of obesity and associated health issues.
- Obesity links to metabolic disorders, cardiovascular diseases, and cancers.
- Understanding molecular mechanisms of anti-adipogenic agents is crucial.
Purpose of the Study:
- To investigate the anti-adipogenic activity of scutellarin (1).
- To elucidate the molecular mechanisms underlying scutellarin's effects on adipocyte differentiation.
- To explore the therapeutic potential of scutellarin for obesity-related conditions.
Main Methods:
- Utilized 3T3-L1 preadipocytes to assess anti-adipogenic effects.
- Quantified cellular lipid accumulation to measure differentiation.
- Analyzed mRNA expression of key adipogenic transcription factors (PPARγ, C/EBPα, C/EBPβ, PPARα).
- Employed computational modeling to predict scutellarin's binding and activation of PPAR isoforms.
Main Results:
- Scutellarin significantly reduced lipid accumulation in differentiating 3T3-L1 cells.
- Downregulated mRNA expression of PPARγ and C/EBPα was observed.
- PPARα mRNA levels were dose-dependently upregulated by scutellarin.
- Computational modeling suggested scutellarin binds to PPARα, γ, and δ, activating PPARα via a specific hydrogen bond.
Conclusions:
- Scutellarin attenuates adipocyte differentiation through a mechanism involving PPARα upregulation and PPARγ/C/EBPα downregulation.
- The findings highlight scutellarin's potential as a therapeutic agent for obesity and related metabolic diseases.
- Scutellarin's interaction with PPAR isoforms warrants further investigation for drug development.
